Document Preview
  • Full Text
  • Scholarly Journal

C38 UNDERSTANDING THERAPEUTICS IN IPF: Cc-90001, A Second Generation Jun N-Terminal Kinase (JNK) Inhibitor For The Treatment Of Idiopathic Pulmonary Fibrosis

; et al. 
; New York Vol. 195,  (2017): 1.